ArticleHuman vaccines & immunotherapeutics2022

Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures.

Ravish S Haradanhalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.